Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022104 (
irritable bowel syndrome
)
8,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A patient over 40 years of age who complains of lower abdominal pain,
constipation
or diarrhea or both, and increased flatulence should be suspected of having diverticulosis. When pain becomes more severe and persistent, diverticulitis must be considered. Diagnosis depends on roentgen demonstration of the presence of diverticula. Sigmoidoscopy and barium enema study are essential to exclude coexisting disease but in diverticulitis may need to be postponed until severe local and systemic signs of inflammation have subsided. A number of diseases can simulate diverticulitis, and differential diagnosis may present considerable difficulty.
Irritable colon syndrome
and acute appendicitis may be indistinguishable clinically from diverticulitis. Differentiation from carcinoma is usually not difficult, but exclusion of coexistent carcinoma may be impossible except by resection. Ulcerative colitis is also easily distinguished except when, rarely, it coexists. Crohn's disease of the colon is less easily differentiated, especially in patients over 40, in whom the two diseases often coexist. Other colonic diseases, such as ischemic colitis, and pelvic inflammatory diseases usually show characteristic features which make them readily distinguishable from diverticulitis.
...
PMID:Diagnosis and differential diagnosis of colonic diverticulitis. 103 35
Differential measurements of small and large bowel transit times were performed in 13 subjects iwth a radiotelemetering pressure-sensitive capsule incorporating less than 10mugCi of 51-Cr. Six patients had
constipation
. The other seven patients had diarrhoea due to the
irritable bowel syndrome
(3), following vagotomy and pyloroplasty (3), or due to laxative abuse (1). This new method enables the gastric, small intestinal, and colonic transit times to be measured differentially in the same subject. The capsule can be localized in the gut lumen by reference to the characteristic pressure pattern and in relation to bony landmarks by the radioactive marker as frequently as desired without recourse to radiographs. The results show that gastric emptying and small intestinal transit did not differ in
constipation
and diarrhoea. By contrast the mean colonic transit was significantly faster (P smaller than 0.01) in diarrhoea whatever the cause (17.5 plus or minus 4.1 hours) than in
constipation
(118 plus or minus 4.1 hours).
...
PMID:Differential measurement of small and large bowel transit times in constipation and diarrhoea: A new approach. 114 Jun 35
Constipation
and diarrhea are usually defined in terms of frequency of defecation and consistency of stool. However, the subjective component in these symptoms is so great that the objective criteria cannot be satisfactory. An important additional aspect is provided by the analysis of sensations and postures in the three phases of the act of defecation (announcing, emptying, subsequent phase). Taking account of the subjective aspects may contribute to a better differentiation and classification not only of
constipation
and diarrhea but also of such disturbances as organic rectal disease and
irritable colon
.
...
PMID:Psychosomatic aspects of defecation and its disturbances. 117 65
The author states that aside from two major digestive psychosomatic conditions, peptic ulcer and ulcero-hemorragic colitis, one only encounters in the adult a widespread psychosomatic pathology, that is to say: 1 degree phenomena of hysterical conversion (gravidic vomiting for example); 2 degrees digestive phenomena concomitant with emotional reactions (diarrhea and anxiety, hypersecretion and anger,
constipation
and depression etc.); 3 degrees digestive manifestations accompanying anxiety neurosis; 4 degrees authentic functional diseases, such as the
irritable colon
corresponding to a well defined personality structure. The author concludes this article by some considerations of psychosomatic symptoms observed by the psychoanalyst; he specifically relates the role of the body barrier, the implication of reality and finally the very particular fantasies found in these psychosomatic patients.
...
PMID:[Psychoanalytical nosography and digestive pathology (author's transl)]. 123 67
The
irritable bowel syndrome
(
IBS
) is a very common condition in gastroenterology clinics, but yet it is one of the pooly understood. A international working team in Rome, 1988, proposed that
IBS
is a functional intestinal disorder with chronic or recurrent gastrointestinal symptoms without structural or biochemical abnormalities.
IBS
was sub-classified into 3 groups; abdominal pain as the prominent feature with diarrhea, with
constipation
, with both while painless diarrhea and simple
constipation
without pain were excluded from
IBS
. There is a lot of data suggesting that
IBS
has a gut dysmotility, which is influenced by many stimuli (food, hormone, drug, menses, mechanical dilatation), including psychological stress. Moreover, currently available evidences implicate that
IBS
is a more generalized disorder of smooth muscle function not only in the intestine but also outside of the intestine.
...
PMID:[Irritable bowel syndrome--criteria, sub-classification, etiology]. 128 43
In
irritable bowel syndrome
(
IBS
), motility disturbances occur from the upper gastrointestinal tract to the distal colon, where regulatory peptides have a wide-spread distribution. Studies on basal and postprandial plasma levels of different gut hormones show that VIP, CCK, and motilin may be closely related to the symptoms including abdominal pain, diarrhea and
constipation
. In addition, peptide YY and NPY have effects on absorption in the intestine, and some opioid peptides exert actions on colonic motility in
IBS
patients. Recent studies revealed that gall bladder in
IBS
has an abnormal sensitivity to CCK-8, indicating that
IBS
patients has an generalized abnormality of the smooth muscle of the digestive tract. Gut hormones, which act as hormones, neurotransmitters and neuromodulators depending on their releasing site, may therefore play an important role in
IBS
patients.
...
PMID:[Role of gut hormones in irritable bowel syndrome]. 128 45
The
irritable bowel syndrome
(
IBS
) is characterized by alteration in bowel habits (i.e.,
constipation
and/or diarrhea) and abdominal pain, and is most common gastrointestinal disorder in adults. The recurrent abdominal pain (RAP) in children is similar to
IBS
in adults except bowel habits, but there is no settled conception of
IBS
in children. In our department, diagnosis of pediatric
IBS
will be made if the child has; #1 functional gastrointestinal disorders without organic diseases, #2 abdominal pain and other gastrointestinal symptoms continuing more than 3 weeks, #3 psychogenic background factors. We experienced 63 cases of
IBS
(23.5% in all 268 cases) from April 1990 to March 1992 at our pediatric digestive outpatient clinic. They ranged from 4 to 15 years old and about 60% of them were elder than 13 years old. Psychogenic factors were usually related to environment of school life and home. Careful history taking and routine examination were most important for the diagnostic approach. Management of this disease included counseling and drug therapy. Almost all cases reached much better condition 1 to 6 weeks after the therapy started. The combination therapy with psychologist was required in a few cases.
...
PMID:[Irritable bowel syndrome in children]. 128 48
The effects of pinaverium bromide on colonic motility were investigated in a controlled, controlled, cross-over study in 32 patients with
irritable bowel syndrome
.
Constipation
was clearly predominant in one group of 16 patients, and diarrhea in the other group of 16. Manometric measurements were taken of the colonic motor response generated by distention of a balloon inserted to the rectosigmoid junction. Measurements were taken before and one hour after ingestion of two tablets containing placebo or two tablets each containing 50 mg of pinaverium bromide. Following intake of placebo the motility index increased from the basal value in patients with
constipation
, and resistance to distention decreased in the diarrhea group. These changes were attributable to repetition of the mechanical stimulus within a relatively brief time lapse, or more probably to the ingestion of liquid which accompanied intake of tablets. Compared with placebo, pinaverium bromide induced inhibition of both effects. From the therapeutic point of view, the decrease in motility index seen in patients with
irritable bowel syndrome
and
constipation
is particularly interesting.
...
PMID:[Manometric effects of pinaverium bromide in irritable bowel syndrome]. 129 86
This study describes the effect of fibre supplementation on the gastrointestinal symptoms and general wellbeing of patients with constipated
irritable bowel syndrome
. In a single centre, double blind, placebo controlled trial of 3 months duration, a daily supplement of 4.1 g fibre produced no greater change in gastrointestinal symptoms than placebo. Pretreatment
constipation
was related to baseline fibre intake. Overall outcome was the same in treated and control groups; a considerable placebo response was evident. This level of fibre supplementation is not a useful treatment; improving neither
constipation
nor other symptoms. At the outset pain severity correlated with depression score on psychometric testing. Those who felt better at the end of the study scored significantly lower for depression at outset than those who felt no better. In
irritable bowel syndrome
a depressive emotional state profile is a powerful determinant of outcome, shaping the response to treatment, which includes a considerable placebo element.
...
PMID:Irritable bowel syndrome: assessment of psychological disturbance and its influence on the response to fibre supplementation. 131 75
The author claims that dietary treatment of
irritable bowel syndrome
(
IBS
) consists of methods aiming at improvement of abdominal symptoms and functional disorder of the bowel. Patients with
constipation
are recommended to take dietary fiber positively, while those with diarrhea should consume sparingly food which may cool their body. Both should avoid overeating and overdrinking, and have regular dietary habits. In order to improve the functional disorder of the bowel, it is necessary for those patients (1) to be careful not to take often refined cereals or manufactured foods, (2) to eat green and yellow vegetables and seaweeds positively, as well as, protein and fat in proper quantity, and (3) to take care of the well-balanced intake of various kinds of vitamins, minerals and other nutriments.
...
PMID:[Dietary treatment in patients with irritable bowel syndrome]. 133 65
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>